{"database": "lobbying", "table": "lobbying_activities", "rows": [[1200524, "ba92b078-7a91-45c3-b1c1-cf46454b4a0f", "Q4", "MCDERMOTT WILL & SCHULTE LLP", 24338, "ALLERGAN, INC.", 2011, "fourth_quarter", "PHA", "Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation", "Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2012-01-20T07:53:29.500000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1200524"], "units": {}, "query_ms": 64.22668206505477, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}